Loading clinical trials...

Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI) | Clinical Trials | Clareo Health

UNKNOWN

Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI)

Prospective Assessment of Brain Imaging After Aneurysmal of AVM-related Intracranial Hemorrhage

NCT05276934•Erasme University Hospital

Summary

The study is an observational prospective evaluation of an approved and unchanged clinical management, evaluating different diagnosis methods to assess brain perfusion in patients with an aneurysmal or AVM-related intracranial hemorrhage

Detailed Description

The study is a prospective description and evaluation of an approved and unchanged clinical management, evaluating already used different diagnosis methods to assess brain perfusion in patients with atraumatic (aneurysmal, AVM-related, unknown cause) intracranial hemorrhage.

Eligibility

Age

18 - 100 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age ≥ 18 years
•2. Non-traumatic intracranial hemorrhage (subarachnoid hemorrhage secondary to a ruptured aneurysm or AVM, unknown cause, per procedural bleed)
•3. In case of ruptured aneurysm, AVM or other etiology : need to be secured with surgical clipping or endovascular intervention if judged possible
•4. No contra-indication to perfusion imaging
•5. Subject or legal representative is able and willing to give informed consent.

Exclusion Criteria

•1. Traumatic intracranial hemorrhage
•2. Contra-indication to imaging or patient's refusal.

Locations (1)

Erasme Hospital

Brussels, Belgium

Key Dates

Start Date

March 1, 2022

Primary Completion Date

October 20, 2025

Completion Date

December 20, 2025

Last Updated

February 21, 2024

Enrollment

100

ESTIMATED participants

Conditions

Aneurysm, RupturedAneurysmal Subarachnoid HemorrhageArteriovenous MalformationsIntracranial AneurysmIntracranial Hemorrhages

Interventions

Brain computed tomography

DIAGNOSTIC_TEST

Contacts

Comite ethique hopital Erasme

CONTACT

003225553707 comite.ethique@erasme.ulb.ac.be

Boris Lubicz, MD, PhD

CONTACT

003225553998 Boris.Lubicz@erasme.ulb.ac.be

Long Term Follow-up After Embolization of Brain Arteriovenous Malformations

NCT02879071

Arteriovenous Malformations

View study

RECRUITING

DIND in Patients With aSAH : Real World Study

NCT07160088

Aneurysmal Subarachnoid Hemorrhage (aSAH)

View study

RECRUITINGPHASE2

FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage

NCT06409364

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 21, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI)

Inclusion Criteria

Exclusion Criteria

Long Term Follow-up After Embolization of Brain Arteriovenous Malformations

DIND in Patients With aSAH : Real World Study

FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage

Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)

Sonography-guided Resection of Brain Mass Lesions

Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine